Thus dysregulated, unscheduled and unnecessary recombination events and loss of checkpoint controls (whether mediated by drivers of genomic instability such as RAD54B and/or other mechanisms) are attributed to genomic instability in cancer. The gene discussed is RAD54B; the disease is cancer.